THE PHARMA CONGRESS ANNOUNCES AN EXTRA AFTERNOON OR HALF-DAY SPECIALTY FOCUSED SESSIONS ON HIT ISSUES IN PHARMA & DEVICE COMPLIANCE!

Kick off 27th Pharma/Device Ethics & Compliance Congress with an added half-day of high-impact Specialty Sessions on Tuesday afternoon, October 13, featuring four timely, expert-led deep dives on the hottest issues facing pharma and device companies today. Included with your registration, this is a valuable opportunity to gain practical insights, benchmark with peers, and arrive fully prepared for the main three-day event.

Specialty Session 1: Pharmaceutical and Medical Device Pricing and Payment Transformation Updates
Offering an overview of Tariffs, Most Favored Nation, TrumpRX, Direct to Consumer, CMS & CMMI: GENEROUS, GLOBE, GUARD & BALANCE Models, IRA Medicare Drug Price Negotiations, Price Reporting, FDA Regulation, Medicaid Rebates, Medicare Fair Price, 340B and PBMs

Specialty Session 2: Pharmaceutical and Medical Device Advanced Privacy and Security/Cybersecurity Updates
Including a special session by the International Association of Privacy Professionals (IAPP)

Specialty Session 3: Advanced Strategies Coordinating Compliance between Medial Affairs and Sales

Specialty Session 4: Practical Case Studies in the Use of AI by Pharma and Device Company Ethics and Compliance Departments
Including a special session by the Health Care Compliance Association (HCCA)

These special focused sessions and included in your Congress registration fee.